256 results on '"Scheijen, Blanca"'
Search Results
2. Btg1 and Btg2 regulate neonatal cardiomyocyte cell cycle arrest
3. Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma Recurrences
4. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
5. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma
6. Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma
7. Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
8. Multifocal occurrence of extra-abdominal desmoid type fibromatosis – A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case
9. Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1
10. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS
11. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
12. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
13. Pathways towards indolent B-cell lymphoma — Etiology and therapeutic strategies
14. Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population
15. Identification of novel GNAS mutations in intramuscular myxoma using next-generation sequencing with single-molecule tagged molecular inversion probes
16. Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma
17. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival
18. Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways
19. Detection of second primary lymphoma in late diffuse large B-cell lymphoma recurrences
20. Activated FLT3 Receptor Tyrosine Kinase as a Therapeutic Target In Leukemia
21. Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
22. Dendritic cells to prevent cancer: Immune responses against neoantigens after dendritic cell vaccination of Lynch Syndrome patients
23. Mutated Tyrosine Kinases As Therapeutic Targets In Myeloid Leukemias
24. Next-Generation Sequencing-Based Clonality Detection of Immunoglobulin Gene Rearrangements in B-Cell Lymphoma
25. Identification and Characterization of Collaborating Oncogenes in Compound Mutant Mice
26. Abstract 9815: Role for Btg1 and Btg2 in Postnatal Cardiomyocyte Cell Cycle Arrest and Maturation
27. BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia
28. Abstract P448: Role For Btg1 And Btg2 In Postnatal Cardiomyocyte Cell Cycle Arrest And Maturation
29. Next-Generation Sequencing–Based Clonality Assessment of Ig Gene Rearrangements
30. DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia
31. Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma
32. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins
33. Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance
34. Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy
35. Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease
36. High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites
37. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
38. Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies
39. Glucocorticoid Resistance in IKZF1-Deleted BCP-ALL: It Is PTEN Again
40. Tumor suppressors BTG1 and BTG2: Beyond growth control
41. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
42. Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study
43. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients
44. Tumor suppressors BTG1 and BTG2: Beyond growth control.
45. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress
46. Tumor Suppressors BTG1 and IKZF1 Cooperate during Mouse Leukemia Development and Impact Relapse Rate in Childhood Acute Lymphoblastic Leukemia
47. Targeted Locus Amplification & Next Generation Sequencing for the Detection of Recurrent and Novel Gene Fusions for Improved Treatment Decisions in Pediatric Acute Lymphoblastic Leukemia
48. Altered cerebellum development and impaired motor coordination in mice lacking the Btg1 gene: Involvement of cyclin D1
49. High frequency of inactivating tetraspanin CD37mutations in diffuse large B-cell lymphoma at immune-privileged sites
50. Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.